KAY CHRISTINA
SEC insider (Form 3/4/5 filer). CIK 0001064901. Co-Chief Executive Officer at INTEGRATED BIOPHARMA INC (INBP). 6 reported Form 4/5 transactions since Sep 2024; latest on Dec 9, 2025. Located in HILLSIDE, NJ.
Companies KAY CHRISTINA has filed insider reports for
- INTEGRATED BIOPHARMA INC (INBP): Director, Officer, 10% Owner, Co-Chief Executive Officer
KAY CHRISTINA
CIK: 0001064901
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INTEGRATED BIOPHARMA INC
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Dec 9, 2025INBP
INTEGRATED BIOPHARMA INC
AwardDirectStock Option (Right to Buy)
140K shares- - May 21, 2025INBP
INTEGRATED BIOPHARMA INC
AwardDirect144.4K shares at avg. $0.09$13K - May 21, 2025INBP
INTEGRATED BIOPHARMA INC
DispositionDirectStock Option (right to buy)
144.4K shares- - Dec 4, 2024INBP
INTEGRATED BIOPHARMA INC
AwardDirectStock Option (right to buy)
125K shares- - Nov 25, 2024INBP
INTEGRATED BIOPHARMA INC
AwardDirect55.6K shares at avg. $0.09$5K - Nov 25, 2024INBP
INTEGRATED BIOPHARMA INC
DispositionDirectStock Option (right to buy)
55.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 9, 2025 | INBP INTEGRATED BIOPHARMA INC | Award Stock Option (Right to Buy) | 140,000 | - | - | Direct |
| May 21, 2025 | INBP INTEGRATED BIOPHARMA INC | Award | 144,445 | $0.09 | $13,000 | Direct |
| May 21, 2025 | INBP INTEGRATED BIOPHARMA INC | Disposition Stock Option (right to buy) | 144,445 | - | - | Direct |
| Dec 4, 2024 | INBP INTEGRATED BIOPHARMA INC | Award Stock Option (right to buy) | 125,000 | - | - | Direct |
| Nov 25, 2024 | INBP INTEGRATED BIOPHARMA INC | Award | 55,555 | $0.09 | $5,000 | Direct |
| Nov 25, 2024 | INBP INTEGRATED BIOPHARMA INC | Disposition Stock Option (right to buy) | 55,555 | - | - | Direct |
1-6 of 6 transactions